Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease
Observational · No treatment assigned · 1 site · Renmin Hospital of Wuhan University
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Colorectal Cancer, Gastric Cancer and Inflammatory Bowel Diseases. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 to 80
- Any sex
Some of the main requirements, copied from the record:
- Any patient diagnosed with colorectal cancer, gastric cancer, non-malignant disease that requires undergoing surgery.
- Must be willing and able to provide informed consent.
There are also 1 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 1000 participants are expected to take part.
- Start date: 2020-12-23.
- Main results expected around 2023-12-23 (estimate from the record).
- 1 study site listed (1 marked recruiting) in China.
Main thing being measured
- Confirmation of diagnosis by pathologist (Up to 3 years)
In the researchers’ words
The purposes of this study are to collect and store samples including blood, normal and tumor tissue from patients with colorectal cancer or gastric cancer, to collect and store samples including blood and/or normal gastrointestinal tissue (if available) from patients with non-malignant disease (including, but not limited to, inflammatory bowel disease (IBD), gastric ulcer, hemorrhoids or hernia), and to create a…
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Colorectal Cancer; Gastric Cancer; Inflammatory Bowel Diseases; Gastric Ulcer; Hemorrhoids; Hernia |
| Lead sponsor | Renmin Hospital of Wuhan University |
| Enrollment | 1000 (estimated) |
| Start date | 2020-12-23 |
| Primary completion (est.) | 2023-12-23 |
| First posted | 2019-06-04 |
| Last updated | 2022-04-29 |
| Official title | Samples Procurement for Patients With Colorectal Cancer, Gastric Cancer, and Non-malignant Disease Undergoing Surgery |
| ClinicalTrials.gov ID | NCT03972956 |
Interventions
- No intervention will be given to patients. (Other)
Samples are collected at the time of a scheduled surgery that is part of normal treatment. This study will not have any impact on the care or treatment the patient receives.
Full eligibility criteria (from the record)
Inclusion Criteria: * Any patient diagnosed with colorectal cancer, gastric cancer, non-malignant disease that requires undergoing surgery. * Must be willing and able to provide informed consent. Exclusion Criteria: * Subjects whose comorbidities would preclude diagnostic or therapeutic intervention.
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Gastrointestinal Surgery II, Renmin Hospital of Wuhan University | Wuhan, Hubei | China | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.